Adaptation of Clostridium difficile toxin A for use as a protein translocation system

Biochemical and Biophysical Research Communications

Volumn 405, Issue 4, 2011, Pages 570-574

  Kern, Stephanie M ^a   Feig, Andrew L ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Clostridium difficile; Glucosyltransferase; Protein delivery system; Protein transduction; Toxin A

Indexed keywords

BAFILOMYCIN A1; CHIMERIC PROTEIN; CLOSTRIDIUM DIFFICILE TOXIN A; CYSTEINE PROTEINASE; GLUCOSYLTRANSFERASE; HYBRID PROTEIN; LUCIFERASE; PROTEIN;

ACIDIFICATION; ADAPTATION; ANIMAL CELL; ARTICLE; BIOTECHNOLOGY; CELL ACTIVITY; CELL LYSATE; CELLULAR DELIVERY SYSTEM; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG INHIBITION; ENDOSOME; GENE TRANSLOCATION; MAMMAL CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSDUCTION; RECEPTOR BINDING; REPORTER GENE; SIGNAL TRANSDUCTION; VERO CELL;

ANIMALS; BACTERIAL TOXINS; CATALYTIC DOMAIN; CERCOPITHECUS AETHIOPS; ENDOSOMES; ENTEROTOXINS; GENE FUSION; GREEN FLUORESCENT PROTEINS; LUCIFERASES; MACROLIDES; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; VERO CELLS;

CLOSTRIDIUM DIFFICILE; MAMMALIA;

EID: 79951955447     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.070     Document Type: Article

References (34)

1. Dietz G.P., Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 2004, 27:85-131.
2. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 1994, 91:664-668.
3. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269:10444-10450.
4. Takeshima K., Chikushi A., Lee K.K., Yonehara S., Matsuzaki K. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J. Biol. Chem. 2003, 278:1310-1315.
5. Borgatti P., Zauli G., Colamussi M.L., Gibellini D., Previati M., Cantley L.L., Capitani S. Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur. J. Immunol. 1997, 27:2805-2811.
6. Gibellini D., Re M.C., Ponti C., Celeghini C., Melloni E., La Placa M., Zauli G. Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells. Br. J. Haematol. 2001, 112:663-670.
7. Bolton S.J., Jones D.N., Darker J.G., Eggleston D.S., Hunter A.J., Walsh F.S. Cellular uptake and spread of the cell-permeable peptide penetratin in adult rat brain. Eur. J. NeuroSci. 2000, 12:2847-2855.
8. Derossi D., Chassaing G., Prochiantz A. Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 1998, 8:84-87.
9. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 2003, 278:585-590.
10. Demarchi F., di Fagagna F.d'Adda, Falaschi A., Giacca M. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 1996, 70:4427-4437.
11. Kameyama S., Horie M., Kikuchi T., Omura T., Takeuchi T., Nakase I., Sugiura Y., Futaki S. Effects of cell-permeating peptide binding on the distribution of 125I-labeled Fab fragment in rats. Bioconjug. Chem. 2006, 17:597-602.
12. Jank T., Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 2008, 16:222-229.
13. Bartlett J.G., Chang T.W., Gurwith M., Gorbach S.L., Onderdonk A.B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 1978, 298:531-534.
14. Kyne L., Farrell R.J., Kelly C.P. Clostridium difficile. Gastroenterol. Clin. North Am. 2001, 30:753-777. ix-x.
15. Albesa-Jove D., Bertrand T., Carpenter E.P., Swain G.V., Lim J., Zhang J., Haire L.F., Vasisht N., Braun V., Lange A., Von Eichel-Streiber C., Svergun D.I., Fairweather N.F.., Brown K.A. Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS. J. Mol. Biol. 2010, 396:1260-1270.
16. Pruitt R.N., Chambers M.G., Ng K.K., Ohi M.D., Lacy D.B. Structural organization of the functional domains of Clostridium difficile toxins A and B. Proc. Natl. Acad. Sci. USA 2010, 107:13467-13472.
17. von Eichel-Streiber C., Sauerborn M., Kuramitsu H.K. Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases. J. Bacteriol. 1992, 174:6707-6710.
18. Ho J.G., Greco A., Rupnik M., Ng K.K. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl. Acad. Sci. USA 2005, 102:18373-18378.
19. Qa'Dan M., Spyres L.M., Ballard J.D. PH-induced conformational changes in Clostridium difficile toxin B. Infect. Immun. 2000, 68:2470-2474.
20. Barth H., Pfeifer G., Hofmann F., Maier E., Benz R., Aktories K. Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J. Biol. Chem. 2001, 276:10670-10676.
21. Pfeifer G., Schirmer J., Leemhuis J., Busch C., Meyer D.K., Aktories K., Barth H. Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J. Biol. Chem. 2003, 278:44535-44541.
22. Reineke J., Tenzer S., Rupnik M., Koschinski A., Hasselmayer O., Schrattenholz A., Schild H., Von Eichel-Streiber C. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 2007, 446:415-419.
23. Egerer M., Giesemann T., Jank T., Satchell K.J., Aktories K. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J. Biol. Chem. 2007, 282:25314-25321.
24. Sheahan K.L., Cordero C.L., Satchell K.J. Autoprocessing of the Vibrio cholerae RTX toxin by the cysteine protease domain. EMBO J. 2007, 26:2552-2561.
25. Just I., Selzer J., Wilm M., Von Eichel-Streiber C., Mann M., Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995, 375:500-503.
26. Hofmann F., Busch C., Prepens U., Just I., Aktories K. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem. 1997, 272:11074-11078.
27. A. Kerzmann, Ph.D. Thesis, Mechanistic analysis of Clostridium difficile toxin A. Indiana University, Bloomington, IN, 2009.
28. Shaner N.C., Steinbach P.A., Tsien R.Y. A guide to choosing fluorescent proteins. Nat. Methods 2005, 2:905-909.
29. Tannous B.A., Kim D.E., Fernandez J.L., Weissleder R., Breakefield X.O. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol. Ther. 2005, 11:435-443.
30. Rupnik M., Pabst S., Rupnik M., von Eichel-Streiber C., Urlaub H., Soling H.D. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 2005, 151:199-208.
31. Frisch C., Gerhard R., Aktories K., Hofmann F., Just I. The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis. Biochem. Biophys. Res. Commun. 2003, 300:706-711.
32. Suzuki T., Usuda S., Ichinose H., Inouye S. Real-time bioluminescence imaging of a protein secretory pathway in living mammalian cells using Gaussia luciferase. FEBS Lett. 2007, 581:4551-4556.
33. Barth H., Blocker D., Behlke J., Bergsma-Schutter W., Brisson A., Benz R., Aktories K. Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification. J. Biol. Chem. 2000, 275:18704-18711.
34. Geissler B., Tungekar R., Satchell K.J. Identification of a conserved membrane localization domain within numerous large bacterial protein toxins. Proc. Natl. Acad. Sci. USA 2010, 107:5581-5586.